Intracranial application of IMRT based radiosurgery to treat multiple or large irregular lesions and verification of infra-red frameless localization system
- 435 Downloads
We have employed a frameless localization system for intracranial radiosurgery, utilizing a custom biteblock with fiducial markers and an infra-red camera for set-up and monitoring patient position. For multiple brain metastases or large irregular lesions, we use a single-isocenter intensity-modulated approach. We report our quality assurance measurements and our experience using Intensity Modulated Radiosurgery (IMRS) to treat such intracranial lesions. A phantom with integrated targets and fiducial markers was utilized to test the positional accuracy of the system. The frameless localization system was used for patient setup and target localization as well as for motion monitoring during treatment. Inverse optimization planning gave satisfactory dose coverage and critical organ sparing. Patient setup was guided by the infrared camera through fine adjustment in three translational and three rotational degrees for isocenter localization and verified by orthogonal kilovoltage (kV) images, taken before treatment to ensure the accuracy of treatment. The relative localization of the camera based system was verified to be highly accurate along three translational directions of couch motion and couch rotation. After verification, we began treating patients with this technique. About 8–12 properly selected fixed beams with a single isocenter were sufficient to achieve good dose coverage and organ sparing. Portal dosimetry with an Electronic Portal Imaging Device (EPID) and kV images provided excellent quality assurance for the IMRS plan and patient setup. The treatment time was less than 60 min to deliver doses of 16–20 Gy in a single fraction. The camera-based system was verified for positional accuracy and was deemed sufficiently accurate for stereotactic treatments. Single isocenter IMRS treatment of multiple brain metastases or large irregular lesions can be done within an acceptable treatment time and gives the benefits of dose-conformity and organ-sparing, easy plan QA, and patient setup verification.
KeywordsFrameless Radiosurgery Intensity modulated Infra-red
Radiosurgery has a well-established role in the treatment of intracranial neoplasms both benign and malignant [1, 2, 3, 4, 5, 6]. Initially developed by Lars Leksell, the Gamma Knife® remains the oldest treatment method and the gold standard for intracranial radiosurgical treatments . As linear accelerator (linac) technology has advanced, however, linac-based radiosurgery has been increasingly adopted [8, 9]. Similar to Gamma Knife® treatment, linac-based radiosurgery has generally been performed using a frame-based system to provide stereotactic guidance.
In order to provide assurance of both patient immobilization and positioning, stereotactic radiosurgery (SRS) has required the patient to have a rigid head-frame affixed to the calvarium. The use of this system provides a 3-dimensional coordinate grid within which any point can be reliably located through the use of the external system alone. This frame is secured using four pins which screw into the calvarium and provide a means for attaching the frame to the treatment table. Patients are generally required to wear this frame for 7–8 h as imaging and treatment planning is performed just prior to treatment delivery. Treatments usually last 15 min per isocenter with mean values for total treatment times on Gamma Knife® Model B, C, and Perfexion recently reported to be 131.0, 129.4, and 114.8 min, respectively .
A recently-developed technology allowing frameless intracranial radiosurgery has been described [11, 12, 13, 14]. This treatment offers the allure of avoiding the rigid head frame, with the potential negative of diminished positioning accuracy. Clearly, the accuracy of detecting and reporting of fiducial positions by the camera system plays a crucial role in the SRS or Intensity Modulated Radiosurgery (IMRS) procedure [15, 16]. A systematic investigation to quantify the accuracy of the infra-red camera system is therefore of great importance. We describe here the accuracy of such a system, as well as our use of the system for the treatment of multiple intracranial target lesions or large irregularly-shaped lesions [17, 18].
Methods and materials
After reseat verification, the patient proceeds to CT (computed tomography) simulation with the bite-block in position. For better tumor delineation, the CT image set is fused with magnetic resonance (MR) images. Since the immobilization head mask and the bite-block are not used in the MR scan, it can be scheduled before or after CT simulation. The treatment plan is done using a single isocenter and multiple static IMRT beams. The treatment plan, together with the CT images, is sent to the optical guidance computer, where the fiducial locations can be digitized. During treatment delivery, the optical guidance camera tracks the positions of the fiducial markers in real time, and treatment delivery can be manually interrupted by the therapist, if a significant positioning error is observed. We have used a threshold of 0.5–0.75 mm for treatment interruption and repositioning. Therapists may enter the treatment room to re-adjust the patient position using the optical guidance system.
The frameless system serves two purposes. First, the system can be used for initial patient positioning. The system tracks the positions of the fiducial array for a patient and compares them with the positions localized in the planning CT, as well as pre-calibrated data to determine the target location relative to the isocenter of the treatment machine. Second, the optical guidance camera monitors intrafraction motion by continually assessing the positions of the reflective fiducial markers, allowing treatment interruption in the event of an unacceptable change in patient position.
Initial quality assurance procedures
After making known shifts with the floor stand along the lateral, longitudinal and vertical directions, the reported position from the camera system was recorded. The same procedure was then repeated with the phantom mounted to the couch for greater lateral shifts. Finally, the couch was set at angles based on the camera readings and the digital couch rotations were recorded.
Implementation of patient treatments
After confirming the positional accuracy of the optical guidance system, we began to use the system for radiosurgical treatment of patients. Treatment planning was done using axial images from both a treatment planning MR and CT. Both MR and CT scans were done at 1.25 mm spacing and a 512 × 512 matrix size. A 1.25 mm interval was selected, because the entire head, including the biteblock, must be included in the imaging field. Although we feel that this will not compromise our accuracy, slight differences may be observed in comparison to studies that use 1.0 mm spacing. The MR series used was a T1 weighted post-contrast image set; no intravenous or oral contrast was used for acquisition of the CT images. The fusion of MR and CT was carried out in the FastPlan System (Varian Medical Systems, Palo Alto, CA) and the adequacy of the fusion was confirmed visually by the treating neurosurgeon. The fused image sets were exported to the Varian Eclipse Treatment Planning System for IMRS planning.
Target lesions as well as critical organs-at-risk (OAR) were segmented manually. Critical structures included: bilateral eyes and optic nerves, optic chiasm, brainstem, as well as uninvolved brain. The clinical target volume (CTV) consisted of all visualized tumor on either image set. A 2 mm margin was normally added to create a PTV, and reduced to 1 mm if close to a critical organ. For patients with a larger reseating verification error (>0.75 mm), a margin of 3 mm may be used. A single isocenter was used to treat multiple lesions, with 8–12 carefully selected beams with fixed gantry angles. The number of lesions treated with a single isocenter ranged from 1 to 13. Prescribed doses were 16–20 Gy with appropriate isodose selection by the treating physician based on the volume: 16 Gy for large lesions and 20 Gy for smaller lesions, following the monograph of the Radiosurgery Dose–Volume Relationship similar to what is used in Gamma Knife® treatments. The prescription dose was to the PTV. An isodose line of 88–93% was normally selected to cover 95–98% of the PTV. The gantry angle and couch rotation of each beam was carefully selected and evaluated in the beam’s eye view (BEV) to provide optimal organ sparing and target coverage. All the beams were designed to have minimal overlap with each other and, as a whole, covered a solid angle as large as possible.
The sliding-window technique was used in all the IMRS delivery, with a selected dose rate of 1000 MU/min; maximum MU per beam is 1999 and maximum field size (jaw setting) is 15 cm × 15 cm. It was found that with proper gantry and couch orientations, the field size of 15 cm × 15 cm could cover almost all of the lesions. In case a lesion was not covered properly by one beam, it could still be covered by other beams at different orientations. For patient-related IMRT quality assurance, the planar dose distribution was verified for each beam using portal dosimetry on an as 1000 EPID detector prior to patient treatment [19, 20].
In order to combine the results from the floor stand and the couch mount, the lateral home position of the couch is re-set to 0.0 cm, and the right and left shifts given either by floor stand or by couch, as well as the camera readings, are all converted to positive numbers and plotted together in Fig. 4a. The correlation of lateral shifts of camera readings and actual known shifts yields a perfect match of a straight line in Fig. 4a, of a slope = 1 with R 2 = 1. The same approach is applied to the longitudinal shifts in Fig. 4b and rotational in Fig. 4d. The vertical couch home position is kept unchanged at 22.1 cm such that the up and down shifts are separated in Fig. 4c. In each measurement, the correlation results in a straight line of a slope = 1 with R 2 = 1. The resolution of the camera readings is 0.1 mm in all three translational directions and 0.1 degree in rotational axes. The excellent agreement of the camera system and the actual fiducial positions confirmed the accuracy of the optical guided frameless positioning system. The utilization of portal dosimetry and kV images as verification provided further quality assurance for the IMRS plan and patient setup.
Stereotactic guidance provides a reliable and reproducible surrogate through which any point can be accurately localized. The use of a rigid head frame maintains stability in positioning, preventing patient motion during treatment delivery. This system allows for confidence in the accurate delivery of very high doses to target lesions with very small expansions for setup uncertainty . However, many patients are resistant to the head frame, and there is morbidity associated with its use. Frameless radiosurgery can offer the patient the advantages of high-dose, single-fraction treatment without requiring the head frame. Reported experience with frameless radiosurgery remains limited. The largest series to date includes 64 patients, most of whom also received surgical resection, whole brain radiation treatment, or both. In this series, overall local control was similar to that reported for frame-based radiosurgery at 88% [14, 22, 23, 24]. Treatment plans on this frameless series employed 1–7 isocenters and 5–35 treatment arcs.
Instead of a multiple-isocenter approach, we have used a single-isocenter, intensity modulated approach for the treatment of patients with multiple intracranial targets or large, irregularly shaped targets. In all cases a single treatment fraction was able to deliver adequate target coverage and sparing of nearby critical normal structures. In a previous analysis of ten patients treated with our single-isocenter technique, the median maximal and minimal PTV coverage was found to be 107 and 87%, respectively, with a median integral dose to normal brain of 6.2 Gy . Additionally, in a side-by-side comparison of a patient planned using both a single- and multiple-isocenter approach, median integral dose to brain was 4.5 and 1.6 Gy for a single- versus multiple-isocenter plan, respectively. Toxicity was found to be generally mild and acceptable. These previous results in combination with our current quality assurance analysis suggest that this technique may offer a more streamlined approach to treatment planning without compromising the quality of treatment.
As a comparison, the hot spot inside the PTV of an IMRS plan is typically 15–20% greater than the prescribed dose, whereas the dose to the center of each lesion is twice greater than the prescribed dose in Gamma Knife® and 20% or higher in cone-based arc linac plans. On the other hand, the dose fall-off outside PTV in IMRS plans is less rapid than that in Gamma Knife® or in a cone based arc plan, causing the integral dose to normal brain to be slightly higher with IMRS. These observations are better demonstrated in dose–volume histograms (DVH) from PTV and normal brain for IMRS plans, such as those shown in Fig. 5. Although integral dose to normal brain was increased, the clinical significance of this elevation is unclear. Treatment with single-isocenter IMRS was well-tolerated, with minimal acute toxicity reported by our patients in this series. Long-term assessment of post-IMRS patients, including an analysis of local control, toxicity, and survival outcomes, is currently underway and will help to define the true benefits and risks of this technique.
The use of a frameless technique offers additional patient convenience. Many patients are resistant to the head frame, and find it difficult to wear for the number of hours required. Frameless techniques not only alleviate this problem for single-fraction treatments, but also offer the option of hypofractionated treatment or single-fraction treatment done on a separate day from treatment planning . In addition, the total treatment time for patient setup validation and dose delivery was about 45 min to deliver doses of 16–20 Gy in each case. Patients with larger PTV can be treated with multiple fractions, typically of a prescription dose 6 Gy per fraction, a total of 30 Gy delivered in five fractions, which is made possible only by the use of frameless localization system.
Our quality assurance procedures have shown the optical guidance system to be accurate and reliable; a further advantage of its use is the ability for intrafraction monitoring of patient position. The system allows for treatment interruption if the measured displacement of the fiducial markers is outside the predetermined tolerances.
The patient setup, after target localization through the optical guidance camera system, is verified by the orthogonal KV-image pair using OBI and comparing with the DRR images. KV image–DRR comparison serves as a verification tool to ensure patient positioning accuracy prior to the radiation treatment and is not routinely used as a patient repositioning tool in the IMRS treatment.
In some cases, due to issues with bite-block reseating, where isocenter misalignment is identified as 2 mm or greater when matching KV images with DRRs, patient treatment may proceed as IMRT treatment without utilizing the optical guidance system. This is a clinical decision, made after images have been reviewed by therapist, physicist, and physician together, and the patient is re-positioned based on OBI to make isocenter shift prior to the radiation treatment.
For patients with dentures, we have found that with the help of denture adhesive treatment can proceed with CT simulation and keep the reproducibility at treatment. This frameless immobilization may not be suitable to those who can not hold the bite block in place. For those patients, IMRT treatment may be a better approach.
Ours is a novel strategy-frameless radiosurgical simultaneous treatment of multiple intracranial targets with a single-isocenter intensity modulated plan. We believe this is an appealing alternative to conventional frame-based systems, offering both convenience and comfort to patients while maintaining overall plan quality.
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
- 17.Wang J, Rice R (2007) SU-FF-T-448: verification of infra-red camera localization system for stereotactic external beam treatment. Med Phys 34(6):2504–2505Google Scholar
- 19.Ting J (2005) Commissioning and dosimetric quality assurance. In A Mundt, JC Roeske (eds) Intensity modulated radiation therapy, a clinical perspective. Decker Inc., HamiltonGoogle Scholar